BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27534788)

  • 1. [Staging and Treatment Response Evaluation in Malignant Lymphomas - Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification)].
    Sýkorová A; Pytlík R; Móciková H; Belada D; Benešová K; Papajík T; Janíková A; Šálek D; Procházka V; Vokurka S; Campr V; Klener P; Kubáčková K; Trněný M
    Klin Onkol; 2016; 29(4):295-302. PubMed ID: 27534788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging and response assessment in lymphomas: the new Lugano classification.
    Cheson BD
    Chin Clin Oncol; 2015 Mar; 4(1):5. PubMed ID: 25841712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revised staging system for malignant lymphoma based on the Lugano classification.
    Munakata W; Terauchi T; Maruyama D; Nagai H
    Jpn J Clin Oncol; 2019 Oct; 49(10):895-900. PubMed ID: 31504700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT for Staging; Past, Present, and Future.
    El-Galaly TC; Gormsen LC; Hutchings M
    Semin Nucl Med; 2018 Jan; 48(1):4-16. PubMed ID: 29195617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.
    Barrington SF; Mikhaeel NG; Kostakoglu L; Meignan M; Hutchings M; Müeller SP; Schwartz LH; Zucca E; Fisher RI; Trotman J; Hoekstra OS; Hicks RJ; O'Doherty MJ; Hustinx R; Biggi A; Cheson BD
    J Clin Oncol; 2014 Sep; 32(27):3048-58. PubMed ID: 25113771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of Relapsed and Refractory Hodgkin Lymphoma - Recommendations of the Czech Hodgkin Lymphoma Study Group].
    Móciková H; Marková J; Gahérová Ľ; Král Z; Sýkorová A; Belada D; Procházka V; Martinková L; Papajík T; Kozák T
    Klin Onkol; 2016; 29(5):342-346. PubMed ID: 27739312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2-Technical).
    Ricard F; Barrington S; Korn R; Brueggenwerth G; Trotman J; Cheson B; Salles G; Schwartz L; Goldmacher G; Jarecha R; Narang J; Broussais F; Galette P; Liu M; Bajpai S; Perlman E; Gillis J; Smalberg I; Terve P; Zahlmann G; Schmid A
    J Nucl Med; 2023 Feb; 64(2):239-243. PubMed ID: 35835581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1-Clinical).
    Ricard F; Cheson B; Barrington S; Trotman J; Schmid A; Brueggenwerth G; Salles G; Schwartz L; Goldmacher G; Jarecha R; Narang J; Broussais F; Galette P; Liu M; Bajpai S; Perlman E; Gillis J; Smalberg I; Terve P; Zahlmann G; Korn R
    J Nucl Med; 2023 Jan; 64(1):102-108. PubMed ID: 35835580
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Tamayo P; Martín A; Díaz L; Cabrero M; García R; García-Talavera P; Caballero D
    Rev Esp Med Nucl Imagen Mol; 2017; 36(5):312-321. PubMed ID: 28483374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up.
    Karls S; Shah H; Jacene H
    Semin Nucl Med; 2018 Jan; 48(1):37-49. PubMed ID: 29195616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Treatment with Crizotinib on Non-small Cell Lung Carcinoma with ALK Translocation in the Czech Republic.
    Miloš P; Jana S; Vítězslav K; Monika Š; Leona K; Jaromír R; Renata C; Markéta Č; Andrea B; Juraj K; Michal H; Milada Z; Marek K; Helena Č; Martin S
    Klin Onkol; 2018; 31(3):207-212. PubMed ID: 30441974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current Progresses in Developing PET Radiopharmaceuticals for Patients in the Czech Republic].
    Adam J; Demlová R; Řehák Z
    Klin Onkol; 2016; 29 Suppl 4():S95-100. PubMed ID: 27846727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3-5 October 2012.
    Meignan M; Barrington S; Itti E; Gallamini A; Haioun C; Polliack A
    Leuk Lymphoma; 2014 Jan; 55(1):31-7. PubMed ID: 23763460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
    Specht L
    Semin Radiat Oncol; 2007 Jul; 17(3):190-7. PubMed ID: 17591566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT.
    Yoo KH
    Blood Res; 2022 Apr; 57(S1):75-78. PubMed ID: 35483930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update on the use of FDG-PET/CT in malignant lymphoma].
    Terauchi T
    Rinsho Ketsueki; 2016; 57(10):2008-2012. PubMed ID: 27795508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging for Staging and Response Assessment in Lymphoma.
    Johnson SA; Kumar A; Matasar MJ; Schöder H; Rademaker J
    Radiology; 2015 Aug; 276(2):323-38. PubMed ID: 26203705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy-related Cognitive Impairment in Patients with Hodgkin Lymphoma - Pathophysiology and Risk Factors].
    Fayette D; Gahérová Ľ; Móciková H; Marková J; Kozák T; Horáček J
    Klin Onkol; 2017; 30(2):93-99. PubMed ID: 28397504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
    Ceriani L; Martelli M; Gospodarowicz MK; Ricardi U; Ferreri AJ; Chiappella A; Stelitano C; Balzarotti M; Cabrera ME; Cunningham D; Guarini A; Zinzani PL; Giovanella L; Johnson PW; Zucca E
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):42-49. PubMed ID: 27839910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of EGFR Mutations in Circulating Tumor DNA (ctDNA) Retrieved from Plasma - Interlaboratory Quality Assessment in the Czech Republic.
    Linda Č; Markéta K; Ivana T; Eva P; Milada M; Hana V; Ondřej H; Karolína B; Jiří D; Monika B; Pavel D
    Klin Onkol; 2018; 31(5):353-360. PubMed ID: 30541321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.